Rx Name [FLUDARABINE, 1000]
|
|
FLUDARABINE 50MG INJ (INP/AHI)
|
|
|
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
Initial treatment of advanced B-cell chronic lymphocytic leukaemia (CLL) or after first line treatment in patients with sufficient bone-marrow reserves.
|
|
|
Fludarabine has a potent immunosuppresive effect. Patients treated with fludarabine are more prone to serious bacterial, opportunistic fungal, and viral infections, and prophylactic therapy can be used in those at risk.Anaemia; appetite decreased; asthenia; bone marrow depression (may be cumulative); chills; cough; diarrhoea; fever; increased risk of infection; malaise; mucositis; nausea; neoplasms; nerve disorders; neutropenia; oedema; stomatitis; thrombocytopenia; vision disorders; vomiting.
|
|
|
40 mg/m2 for 5 days every 28 days, usually given for 6 cycles.
By intravenous injection, or by intravenous infusion. |
|
|
|
|
|
|
|
|
|
|
|
|